CIK 0001703057 · Large accelerated filer
AbCellera Biologics Inc.
Sign in to watch- Ticker
- ABCL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- British Columbia, Canada
- Entity type
- operating
- Phone
- (604) 559-9005
- Business address
- 150 W 4TH AVENUE, VANCOUVER, British Columbia, Canada, V5Y 1G6
- 8-K Event Results of operations · Regulation FD disclosure
- 8-K Event Other events
- 4 Open-market buy Director bought 20,000 shares at $4.91 ($98,200)
- 4 Open-market buy Chief Operating Officer bought 20,000 shares at $5.19 ($103,800)
- 4 Option exercise Chief Executive Officer acquired 56,125 shares (option exercise)
- 4 Open-market buy Director bought 30,000 shares at $5.90 ($177,000)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations · Regulation FD disclosure
- 8-K Event Shareholder vote results
- 4 Option exercise Chief Executive Officer acquired 56,125 shares (option exercise)
- 4 Open-market buy Chief Financial Officer bought 14,500 shares at $6.85 ($99,325)
- 4 Open-market buy 10% owner bought 153,000 shares at $6.52 ($997,728)
- 8-K Event Material agreement · New debt or obligation · Other events
- 4 Option exercise Chief Operating Officer acquired 250,000 shares (option exercise)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations · Regulation FD disclosure
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- ARS Other Annual Report to Security Holders
- SC 13D/A Stake Beneficial Ownership Report
Page 7 of 17 · 325 filings